Evidence map›Paper›PMID 33626204›Full record

ArticleThe Journal of pathology2021

Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure.

Fiorella Calabrese, Federica Pezzuto, Francesco Fortarezza, Annalisa Boscolo, Francesca Lunardi, Chiara Giraudo, Annamaria Cattelan, Claudia Del Vecchio, Giulia Lorenzoni, Luca Vedovelli and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Advances in Biomarkers for Diagnosis and Treatment of ARDS.Diagnostics (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Fiorella CalabreseDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.ORCID https://orcid.org/0000-0001-5351-9226
Federica PezzutoDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Francesco FortarezzaDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.ORCID https://orcid.org/0000-0002-8954-5888
Annalisa BoscoloDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Francesca LunardiDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Chiara GiraudoDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Annamaria CattelanDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Claudia Del VecchioDepartment of Molecular Medicine, University of Padua Medical School, Padua, Italy.
Giulia LorenzoniDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Luca VedovelliDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Nicolò SellaDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Marco RossatoDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Federico ReaDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Roberto VettorDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Mario PlebaniDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Emanuele CozziDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Andrea CrisantiDepartment of Molecular Medicine, University of Padua Medical School, Padua, Italy.
Paolo NavalesiDepartment of Medicine, University of Padua Medical School, Padua, Italy.
Dario GregoriDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
University of Padua · IT

Funding

University of Padua/Intesa San Paolo Vita Bank 2020A08
6 · The paper itself

Abstract

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pneumopathy is characterized by a complex clinical picture and heterogeneous pathological lesions, both involving alveolar and vascular components. The severity and distribution of morphological lesions associated with SARS-CoV-2 and how they relate to clinical, laboratory, and radiological data have not yet been studied systematically. The main goals of the present study were to objectively identify pathological phenotypes and factors that, in addition to SARS-CoV-2, may influence their occurrence. Lungs from 26 patients who died from SARS-CoV-2 acute respiratory failure were comprehensively analysed. Robust machine learning techniques were implemented to obtain a global pathological score to distinguish phenotypes with prevalent vascular or alveolar injury. The score was then analysed to assess its possible correlation with clinical, laboratory, radiological, and tissue viral data. Furthermore, an exploratory random forest algorithm was developed to identify the most discriminative clinical characteristics at hospital admission that might predict pathological phenotypes of SARS-CoV-2. Vascular injury phenotype was observed in most cases being consistently present as pure form or in combination with alveolar injury. Phenotypes with more severe alveolar injury showed significantly more frequent tracheal intubation; longer invasive mechanical ventilation, illness duration, intensive care unit or hospital ward stay; and lower tissue viral quantity (p < 0.001). Furthermore, in this phenotype, superimposed infections, tumours, and aspiration pneumonia were also more frequent (p < 0.001). Random forest algorithm identified some clinical features at admission (body mass index, white blood cells, D-dimer, lymphocyte and platelet counts, fever, respiratory rate, and PaCO

Indexed as

Machine LearningAgedAged, 80 and overCOVID-19FemaleHumansMaleRespiratory Distress SyndromeRespiratory InsufficiencySARS-CoV-2Vascular System Injuriesacute respiratory failurealveolar injuryCOVID-19SARS-CoV-2vascular injury

Identifiers

PMID33626204
PMCPMC8014445
OpenAlexW3131679787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.